Novavax Pins COVID-19 Hopes On Ex-US, Booster Markets

Delay In FDA Filing Until Q4

 
• By Alaric DeArment
COVID-19 vaccine
Novavax plans a flurry of ex-US filings for its COVID-19 vaccine amid another delay in its EUA filing in the US • Source: Shutterstock

More from Earnings

More from Business